Navigation Links
Lexicon Announces Proposed $95 Million Common Stock Offering
Date:3/8/2010

This press release does not constitute an offer to sell, or the solicitation of an offer to buy, these securities, nor will there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale is not permitted.  The offering of these securities will be made only by means of a preliminary prospectus supplement and accompanying prospectus, copies of which may be obtained from Morgan Stanley & Co. Incorporated, Attn:  Prospectus Department, 180 Varick Street, 2nd Floor, New York, New York 10014, telephone:  (866) 718-1649, or by emailing prospectus@morganstanley.com, or from J.P. Morgan Securities Inc., Attention: Broadridge Financial Solutions at 1155 Long Island Avenue, Edgewood, New York 11717, or by telephone at 866-803-9204.

The issuer has filed a registration statement (including a base prospectus) with the Securities and Exchange Commission, or SEC, for an offering to which this communication relates.  Before you invest, you should read the prospectus in that registration statement and related prospectus supplements and other documents that the issuer has filed or will file with the SEC for more complete information about the issuer and this offering.  You may get these documents for free by visiting EDGAR on the SEC website at

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Lexicon to Report Fourth Quarter and Year End 2009 Financial Results on February 23, 2010
2. Lexicon Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference
3. Lexicon to Host Conference Call and Webcast to Review Top-Line Phase 2 Results From Diabetes Trial
4. Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009
5. Lexicon Announces Positive Phase 2 Results of LX1031 in Non-Constipating Irritable Bowel Syndrome
6. Lexicon Announces Completion of Public Offering of Common Stock
7. Lexicon Announces Pricing of Common Stock in Public Offering
8. Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes
9. Lexicons Drug Candidate LX1032 for Carcinoid Syndrome Receives Orphan Drug Designation From EMEA
10. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 First Quarter Results
11. Lexicon Presents Clinical Data on LX1032 for Carcinoid Syndrome at European Neuroendocrine Tumor Society Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... , Sept. 30, 2014 /PRNewswire/ ... CHDX ) today announced the completion of ... for $24.00 per share in cash.  Healthy Harmony is ... Ltd. ("Fosun") and Ms. Roberta Lipson , the ... merger agreement was adopted by Chindex,s stockholders at a ...
(Date:9/30/2014)... Calif. , Sept. 30, 2014  Allakos ... additional $10 million investment from current investors to ... additional financing was completed following achievement of a ... antibody program, and represents an extension of the ... in December 2012. With this additional financing, Allakos ...
(Date:9/29/2014)... SAN DIEGO , 29 septembre 2014 /PRNewswire/ ... Sankyo) (TSE : 4568) et Ambit Biosciences (NASDAQ : AMBI), ... de fusion définitif en vertu duquel Daiichi Sankyo ... en circulation d,Ambit Biosciences à 15 dollars par ... publique d,achat qui sera suivie d,une fusion avec ...
Breaking Medicine Technology:Chindex Completes Go-Private Transaction With Healthy Harmony Holdings, L.P. 2Chindex Completes Go-Private Transaction With Healthy Harmony Holdings, L.P. 3Chindex Completes Go-Private Transaction With Healthy Harmony Holdings, L.P. 4Chindex Completes Go-Private Transaction With Healthy Harmony Holdings, L.P. 5Allakos Inc. Raises Additional $10 Million to Expand its Portfolio and Fund Development of an Additional Antibody for Allergic and Inflammatory Diseases 2Allakos Inc. Raises Additional $10 Million to Expand its Portfolio and Fund Development of an Additional Antibody for Allergic and Inflammatory Diseases 3Allakos Inc. Raises Additional $10 Million to Expand its Portfolio and Fund Development of an Additional Antibody for Allergic and Inflammatory Diseases 4Daiichi Sankyo va acquérir Ambit Biosciences 2Daiichi Sankyo va acquérir Ambit Biosciences 3Daiichi Sankyo va acquérir Ambit Biosciences 4Daiichi Sankyo va acquérir Ambit Biosciences 5Daiichi Sankyo va acquérir Ambit Biosciences 6Daiichi Sankyo va acquérir Ambit Biosciences 7Daiichi Sankyo va acquérir Ambit Biosciences 8Daiichi Sankyo va acquérir Ambit Biosciences 9
... OMAHA, Neb., May 15 Creighton Medical Laboratories, based ... Omaha, announced today that it has become the first ... effective testing method for cancer. The method, called SNP ... laboratories to study cancer for several years. However, Creighton ...
... , in Damaged Tissue and Cells MANDEVILLE, La., ... leading expert in the field of non-surgical skin rejuvenation ... to speed up the healing process of damaged tissue ... a double-blinded, placebo-controlled clinical study of a glycerin-based bruise-reaction ...
Cached Medicine Technology:Creighton Medical Laboratories First to Offer New Cancer Test 2Creighton Medical Laboratories First to Offer New Cancer Test 3Glycerin Proven to Improve Bruising and Swelling Caused By Trauma to Skin 2
(Date:9/30/2014)... Austin, TX (PRWEB) September 30, 2014 ... for Facial Plastic Surgery, has been approved to be ... of Facial Plastic and Reconstructive Surgery (AAFPRS) fellowship program. ... their meeting in Orlando, Florida. , The Educational and ... throughout the medical community. It represents the finest postgraduate ...
(Date:9/30/2014)... September 30, 2014 Gummy teeth ... gum depigmentation treatments for dark gums. Dark gums are ... people feel extremely self-conscious about their smiles. Dr. Farnoosh ... gums. “I am one of the few dental professionals ... have treated celebrities, business leaders, high-ranking officials and patients ...
(Date:9/30/2014)... HealthDay Reporter TUESDAY, Sept. ... supplements won,t prevent the return of a common type of ... In fact, 64.1 percent of those taking fish oil for ... over the course of 16 months, compared to 63.2 ... did not reduce the twin ills of inflammation or oxidative ...
(Date:9/30/2014)... MYERS, Fla. (PRWEB) September 30, 2014 ... Hospital, is giving breast cancer patients a new, more ... surgeries. , Women who undergo mastectomies, biopsies and lumpectomy ... and promote healing. But after seeing her patients describe ... felt compelled to create a new bra in her ...
(Date:9/30/2014)... New York, New York (PRWEB) September 30, 2014 ... will honor Kenro Izu – founder of the nonprofit, ... City on November 6, 2014, for building a hospital ... sustainable pediatric care. , Izu first encountered Cambodia’s ... suffering from a variety of disabilities and illnesses during ...
Breaking Medicine News(10 mins):Health News:Dr. Edward Buckingham Approved to be Fellowship Director for Facial Plastic Surgery 2Health News:Dr. Edward Buckingham Approved to be Fellowship Director for Facial Plastic Surgery 3Health News:Gummy Smile Dentist, Dr. Alex Farnoosh, is Now Offering Gum Depigmentation for Dark Gums 2Health News:Fish Oil Supplements Have Little Effect on Irregular Heartbeat: Study 2Health News:Fish Oil Supplements Have Little Effect on Irregular Heartbeat: Study 3Health News:Surgeon Creates New Bra for Breast Cancer Patients, Post-Surgery 2Health News:Surgeon Creates New Bra for Breast Cancer Patients, Post-Surgery 3Health News:Nobel Prize For Child Advocates Announces 2014 Health Award Honoree 2Health News:Nobel Prize For Child Advocates Announces 2014 Health Award Honoree 3
... WASHINGTON, Sept. 21 Trust for America,s Health ... a new report today featuring a range of evidence-based disease ... reducing costs in communities. , , The ... a summary and examples from an extensive literature review that ...
... , Foundation grants to inspire locally-driven ... PORTLAND, Ore., Sept. 21 The Robert Wood Johnson Foundation ... for Proposal for Partners Investing in Nursing,s Future (PIN), a collaborative ... funding partnerships with local and regional foundations. , ...
... Surgical patients more likely to finish radiation course, study ... and interrupted radiation treatment is a common problem among ... study has found. , Researchers analyzed data from 5,086 ... 1997 and 2003 and found that nearly 40 percent ...
... MD (Sept. 21, 2009) The American Gastroenterological Association ... that the family of the late businessman and photographer, ... a new three-year Research Scholar Award for pancreatic cancer ... Foundation will provide a young investigator with funding and ...
... anyone? Or maybe a big job interview? Dry your palms ... silver lining. Researchers at the Stanford University School of Medicine ... relatively short-term stress can boost the immune system and protect ... this occasional angst seem to last for weeks after the ...
... can blind premature babies are being seen for the first ... Duke University Medical Center. The technology, developed in ... tomography (SD OCT) to create a 3-D picture of the ... way we identify eye conditions in infants," says Cynthia Toth, ...
Cached Medicine News:Health News:New Report Highlights Proven Disease Prevention Programs in Communities 2Health News:New Report Highlights Proven Disease Prevention Programs in Communities 3Health News:New Report Highlights Proven Disease Prevention Programs in Communities 4Health News:Call for Proposals for Partners Investing in Nursing's Future 2Health News:Head, Neck Cancer Treatment Often Not Completed 2Health News:California family honors father with second AGA Foundation Research Scholar Award 2Health News:Short-term stress enhances anti-tumor activity in mice, Stanford study shows 2Health News:Short-term stress enhances anti-tumor activity in mice, Stanford study shows 3Health News:Short-term stress enhances anti-tumor activity in mice, Stanford study shows 4Health News:New device finds early signs of eye disease in preemies 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: